129 related articles for article (PubMed ID: 38604312)
1. FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2.
Zheng L; Shen J; Chen Y; Lin J; Li P; Zhao X; Ren H; Sun Y; Wang Z
Cancer Lett; 2024 Jun; 591():216848. PubMed ID: 38604312
[TBL] [Abstract][Full Text] [Related]
2. Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
Li J; Tian H; Pan J; Jiang N; Yang J; Zhou C; Xu D; Meng X; Gong Z
Cancer Lett; 2017 Oct; 406():36-46. PubMed ID: 28789966
[TBL] [Abstract][Full Text] [Related]
3. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.
Xu J; Zhou W; Yang F; Chen G; Li H; Zhao Y; Liu P; Li H; Tan M; Xiong X; Sun Y
Nat Commun; 2017 Jan; 8():14002. PubMed ID: 28090088
[TBL] [Abstract][Full Text] [Related]
4. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
5. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Skp2 expression and activity and its role in cancer progression.
Chan CH; Lee SW; Wang J; Lin HK
ScientificWorldJournal; 2010 Jun; 10():1001-15. PubMed ID: 20526532
[TBL] [Abstract][Full Text] [Related]
7. Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells.
Chen XM; Xie XB; Zhao Q; Wang F; Bai Y; Yin JQ; Jiang H; Xie XL; Jia Q; Huang G
Mol Med Rep; 2015 Jan; 11(1):105-12. PubMed ID: 25333250
[TBL] [Abstract][Full Text] [Related]
8. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
[TBL] [Abstract][Full Text] [Related]
9. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
Bu W; Luo T
DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922
[TBL] [Abstract][Full Text] [Related]
10. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
11. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
[TBL] [Abstract][Full Text] [Related]
12. The Rho family member RhoE interacts with Skp2 and is degraded at the proteasome during cell cycle progression.
Lonjedo M; Poch E; Mocholí E; Hernández-Sánchez M; Ivorra C; Franke TF; Guasch RM; Pérez-Roger I
J Biol Chem; 2013 Oct; 288(43):30872-82. PubMed ID: 24045951
[TBL] [Abstract][Full Text] [Related]
13. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma.
Xu H; Choe C; Shin SH; Park SW; Kim HS; Jung SH; Yim SH; Kim TM; Chung YJ
Exp Mol Med; 2014 May; 46(5):e97. PubMed ID: 24854087
[TBL] [Abstract][Full Text] [Related]
14. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells.
Zhou H; Zhou L; Guan Q; Hou X; Wang C; Liu L; Wang J; Yu X; Li W; Liu H
Commun Biol; 2023 Aug; 6(1):805. PubMed ID: 37532777
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation.
Vosper J; Masuccio A; Kullmann M; Ploner C; Geley S; Hengst L
Oncotarget; 2015 Feb; 6(5):2889-902. PubMed ID: 25605247
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
Yan J; Yao Z; Hu K; Zhong Y; Li M; Xiong Z; Deng M
Dig Dis Sci; 2015 May; 60(5):1315-24. PubMed ID: 25567052
[TBL] [Abstract][Full Text] [Related]
17. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
Chen JY; Wang MC; Hung WC
J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
[TBL] [Abstract][Full Text] [Related]
18. von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage.
Roe JS; Kim HR; Hwang IY; Cho EJ; Youn HD
Oncogene; 2011 Jul; 30(28):3127-38. PubMed ID: 21358672
[TBL] [Abstract][Full Text] [Related]
19. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
20. Association between F-box-only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis.
Wu S; Qin L; Yang J; Wang J; Shen Y
Cancer Med; 2023 Apr; 12(8):10062-10076. PubMed ID: 36710413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
